An animal model to study health effects during continuous low-dose exposure to the nerve agent VX

Toxicology

Volumn 250, Issue 1, 2008, Pages 32-38

  Rocksén, David ^a,b   Elfsmark, Daniel ^a   Heldestad, Victoria ^c   Wallgren, Karin ^a   Cassel, Gudrun ^a   Göransson Nyberg, Ann ^a  

^a SWEDISH DEFENCE RESEARCH AGENCY   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UMEÅ UNIVERSITY   (Sweden)

Author keywords

Acetylcholinesterase; Low dose; Osmotic pump; Telemetry; VX

Indexed keywords

ACETYLCHOLINESTERASE; METHYLPHOSPHONOTHIOIC ACID S (2 DIISOPROPYLAMINOETHYL) O ETHYL ESTER; THYROXINE;

ANIMAL MODEL; ARTICLE; BLOOD ANALYSIS; BREATHING RATE; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; ENZYME ACTIVITY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; THYROID FUNCTION;

ACETYLCHOLINESTERASE; ANIMALS; BLOOD PRESSURE; CHEMICAL WARFARE AGENTS; CHOLINESTERASE INHIBITORS; CORTICOSTERONE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HEART RATE; MALE; ORGANOTHIOPHOSPHORUS COMPOUNDS; OSMOSIS; RATS; RATS, WISTAR; RESPIRATION; TELEMETRY; THYROID GLAND; THYROXINE; WEIGHT GAIN;

ANIMALIA; RATTUS; RATTUS NORVEGICUS;

EID: 47849114836     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2008.05.015     Document Type: Article

References (43)

1. Atchison C.R., Sheridan R.E., Duniho S.M., and Shih T.-M. Development of a guinea pig model for low-dose, long-term exposure to organophosphorus nerve agents. Toxicol. Mech. Methods 14 (2004) 183-194
2. Augustinsson K.-B., Eriksson H., and Faijersson Y. A new approach to determining cholinesterase activities in samples of whole blood. Clin. Chim. Acta 89 (1978) 239-252
3. Aurbek N., Thiermann H., Szinicz L., Eyer P., and Worek F. Analysis of inhibition, reactivation and aging kinetics of highly toxic organophosphorus compounds with human and pig acetylcholinesterase. Toxicology 224 (2006) 91-99
4. Bazylewicz-Walczak B., Majczakowa W., and Szymczak M. Behavioural effects of occupational exposure to organophosphorus pesticides in female greenhouse planting workers. Neurotoxicology 20 (1999) 819-826
5. Buccafusco J.J. The role of central cholinergic neurons in the regulation of blood pressure and in experimental hypertension. Pharmacol. Rev. 48 (1996) 179-211
6. Burchfield J.L., and Duffy F.H. Organophosphate neurotoxicity: chronic effects of sarin on the electroencephalogram of monkey and man. Neurobehav. Toxicol. Teratol. 4 (1982) 767-778
7. Chambers H.W. Organophosphorus compounds: an overview. In: Chambers H.W., and Levy P. (Eds). Organophosphates: Chemistry, Fate and Effects (1992), Academic Press, San Diego7 3-17
8. Conn C.A., Dokladny K., Ménache M.G., Barr E.B., Kozak W., Kozak A., Wachulec M., Rudolph K., Kluger M.J., and Henderson R.F. Effects of sarin on temperature and activity of rats as a model for gulf war syndrome neuroregulatory functions. Toxicol. Appl. Pharmacol. 184 (2002) 77-81
9. Coordinating Subcommittee, 1985. Possible long term health effects of short term exposure to chemical agents, vol. III, Final Report, Current health status of test subjects. Committee on Toxicology, Board on Toxicology and Environmental Health Hazards, Assembly of Life Sciences, National Academy Press.
10. Crenshaw M.D., Hayes T.L., Miller T.L., and Shannon C.M. Comparison of the hydrolytic stability of S-(N,N-diethylaminoethyl) isobutyl methylphosphonothiolate with VX in dilute solution. J. Appl. Toxicol. 1 (2001) 3-6
11. Curtin B.F., Seetharam K.I., Dhoieam P., Gordon R.K., Doctor B.P., and Nambia M.P. Resveratrol induces catalytic bioscavenger paraoxonase 1 expression and protects against chemical warfare nerve agent toxicity in human cell lines. J. Cell. Biochem. 103 (2007) 1524-1535
12. Duysen E.G., Li B., Xie W., Schopfer L.M., Anderson R.S., Broomfield C.A., and Lockridge O. Evidence for nonacetylcholinesterase targets of organophosphorus nerve agent: supersensitivity of acetylcholinesterase knockout mouse to VX lethality. J. Pharmacol. Exp. Ther. 299 (2001) 528-535
13. Fara J., and Urquhart J. The value of infusion and injection regimens in assessing efficacy and toxicity of drugs. Trends Pharmacol. Sci. 5 1 (1984) 21-25
14. Genovese R.F., Benton B.J., Lee E.H., Shippee S.J., and Jakubowski E.M. Behavioural and biochemical evaluation of sub-lethal inhalation exposure to VX in rats. Toxicology 232 (2007) 109-118
15. Goldman, M., Rosenblatt, L.S., Wilson, B.W., Kawakami, T.G., Culbertson, M.R., Schreider, J.P., Remsen, J.F., Shifrine, M., 1988. Toxicity studies on agent VX. Final report. AD A201397. Ft. Detrick, Frederick, MD, U.S. Army Medical Research and Development Command.
16. Göransson-Nyberg A., Fredriksson S.A., Karlsson B., Lundström M., and Cassel G. Toxicokinetics of soman in cerebrospinal fluid and blood of anaesthetized pigs. Arch. Toxicol. 72 (1998) 459-467
17. Hamilton M.G., Hill I., Conley J., Sawyer T.W., Caneva D.C., and Lundy P.M. Clinical aspects of percutaneous poisoning by the chemical warfare agent VX: effects of application site and decontamination. Mil. Med. 169 (2004) 856-862
18. Haug K.H., Bogen I.L., Osmundsen H., Walaas I., and Fonnum F. Effects on cholinergic markers in rat brain and blood after short and prolonged administration of donepezil. Neurochem. Res. 30 (2005) 1511-1520
19. Henderson R.F., Barr E.B., Blackwell W.B., Clark C.R., Conn C.A., Kalra R., March T.H., Sopori M.L., Tesfaigzi Y., Ménache M.G., and Mash D.C. Response of rats to low levels of sarin. Toxicol. Appl. Pharmacol. 184 (2002) 67-76
20. Hohimer A.R., Davis L.E., and Hatton D.C. Repeated daily injections and osmotic pump infusion of isoproterenol cause similar increases in cardiac mass but have different effects on blood pressure. Can. J. Physiol. Pharmacol. 83 (2005) 191-197
21. Holstege C.P., Kirk M., and Sidell F.R. Chemical warfare nerve agent poisoning. Crit. Care Clin. 13 (1997) 923-942
22. Kant G.J., Shih T.M., Bernton E.W., Fein H.G., Smallridge R.C., and Mongey E.H. Effects of soman on neuroendocrine and immune function. Neurotoxicol. Teratol. 13 (1991) 223-228
23. Karlsson B., Waara L., Fredriksson S.-A., and Koskinen L.-O. The effect of the calcium antagonist nimodipine on the detoxification of soman in anaesthetised rabbits. J. Pharm. Pharmacol. 49 (1997) 296-300
24. Kramer K., and Kinter L.B. Evaluation and applications of radiotelemetry in small laboratory animals. Physiol. Genomics 13 (2003) 197-205
25. Lenz D.E., Maxwell D.M., and Austin L.W. Development of a rat model for subacute exposure to the toxic organophosphate VX. J. Am. Coll. Toxicol. 15 (1997) 69-77
26. Lotinun S., Sibonga J.D., and Turner R.T. Differential effects of intermittent and continuous administration of parathyroid hormone on bone histomorphometry and gene expression. Endocrine 17 (2002) 29-36
27. Marrs T.C., Maynard R.L., and Sidell F.R. Chemical Warfare Agents: Toxicology and Treatment. second ed. (2007), John Wiley & Sons, Chichester
28. McCauley L.A., Lasarev M.R., Higgins G., Rothlein J., Muniz J., Ebbert C., and Phillips J. Work characteristics and pesticide exposures among migrant agricultural families: a community-based research approach. Environ. Health Perspect. 109 (2001) 533-538
29. Moore D.H. Health effects of exposure to low doses of nerve agent-a review of present knowledge. Drug Chem. Toxicol. 21 (1998) 123-130
30. Munro N.B., Ambrose K.R., and Watson A.P. Toxicity of the organophosphate chemical warfare agents GA, GB, and VX: implications for public protection. Environ. Health Perspect. 102 1 (1994) 8-38
31. Nakajima T., Ohta S., Fukushima Y., and Yanagisawa N. Sequelae of sarin toxicity at one and three years after exposure in Matsumoto. Jpn. J. Epidemiol. 9 (1999) 337-343
32. Panel on Anticholinesterase Chemicals, 1982. Panel on Anticholinesterase Chemicals, Possible long term health effects of short term exposure to chemical agents. Anticholinesterases and anticholinergics. Committee on Toxicology and Environmental Health Hazards, Assembly of Life Sciences, vol. I. National Academy Press, Washington.
33. Porterfield S.P. Vulnerability of the developing brain to thyroid abnormalities: environmental insults to the thyroid system. Environ. Health Perspect. 102 2 (1994) 125-130
34. Russell R.W., Booth R.A., Lauretz S.D., Smith C.A., and Jenden D.J. Behavioural, neurochemical and physiological effects of repeated exposures to subsymptomatic levels of the anticholinesterase, soman. Neurobehav. Toxicol. Teratol. 8 (1986) 675-685
35. Scremin O.U., Shih T.M., Huynh L., Roch M., Booth R., and Jenden D.J. Delayed neurologic and behavioural effects of subtoxic doses of cholinesterase inhibitors. J. Pharmacol. Exp. Ther. 304 (2003) 1111-1119
36. Shih T.M. Time course effects of soman on acetylcholine and choline levels in six discrete areas of the rat brain. Psychopharmacology 78 (1982) 170-175
37. Sidell F.R. Soman and sarin: clinical manifestations treatment of accidental poisoning by organophosphates. Toxicol. Clin. 7 (1974) 1-17
38. Sidell F.R., and Groff W.A. The reactivatibility of cholinesterase inhibited by VX and sarin in man. Toxicol. Appl. Pharmacol. 27 (1974) 241-252
39. Sim V.M. Anticholinesterase poisoning. In: Waser P.G. (Ed). Cholinergic Mechanisms (1975), Raven Press, New York 395-398
40. van der Schans M.J., Lander B.J., van der Wiel H., Langenberg J.P., and Benschop H.P. Toxicokinetics of the nerve agent (+/-)-VX in anesthetized and atropinized hairless guinea pigs and marmosets after intravenous and percutaneous administration. Toxicol. Appl. Pharmacol. 191 (2003) 48-62
41. Weese C.B. Gulf war syndrome: questions, some answers, and the deployment surveillance. In: Somani S.M., and Romano J.A. (Eds). Chemical Warfare Agents: Toxicity at Low Levels (2001), CRC Press, Boca Raton 261-299
42. Wiener S.W., and Hoffman R.S. Nerve agents: a comprehensive review. J. Intensive Care. Med. 19 (2004) 22-37
43. Wright B.S., Rezk P.E., Graham J.R., Steele K.E., Gordon R.K., Sciuto A.M., and Nambiar M.P. Acute lung injury following inhalation exposure to nerve agent VX in guinea pigs. Inhal. Toxicol. 18 6 (2006) 437-448